CSIMarket Company Name, Ticker, Industry, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Inc. COP Y/Y Annual
Zimmer Biomet Holdings Inc   (ZBH)
Other Ticker:  
 
 

ZBH's Income from Cont. Operations Growth by Quarter and Year

Zimmer Biomet Holdings Inc 's Income from Cont. Operations results by quarter and year




ZBH Income from Cont. Operations (in millions $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - -130.20 -83.90 333.80
III Quarter September 162.90 194.20 145.80 246.10
II Quarter June 209.80 154.00 142.50 -208.20
I Quarter March 232.70 73.20 197.70 -509.10
FY   605.40 291.20 402.10 -137.40



ZBH Income from Cont. Operations third quarter 2023 Y/Y Growth Comment
Zimmer Biomet Holdings Inc reported decline in Income from Cont. Operations in the third quarter 2023 by -16.12% to $ 162.90 millions, from the same quarter in 2022.
The contraction in the third quarter 2023 Zimmer Biomet Holdings Inc 's Income from Cont. Operations compares unfavorably to the Company's average Income from Cont. Operations doubling of 132.49%.

Looking into third quarter 2023 results within Medical Equipment & Supplies industry 33 other companies have achieved higher Income from Cont. Operations growth. While Zimmer Biomet Holdings Inc ' s Income from Cont. Operations fall of -16.12% ranks overall at the positon no. 1272 in the third quarter 2023.


ZBH Income from Cont. Operations ( Y/Y Growth %) 2023
 2022 2021 2020
IV Quarter December - - - 3.86 %
III Quarter September -16.12 % 33.2 % -40.76 % -43.03 %
II Quarter June 36.23 % 8.07 % - -
I Quarter March 217.9 % -62.97 % - -
FY   - -27.58 % - -

Financial Statements
Zimmer Biomet Holdings Inc 's third quarter 2023 Income from Cont. Operations $ 162.90 millions ZBH's Income Statement
Zimmer Biomet Holdings Inc 's third quarter 2022 Income from Cont. Operations $ 194.20 millions Quarterly ZBH's Income Statement
New: More ZBH's historic Income from Cont. Operations Growth >>


ZBH Income from Cont. Operations (Quarter on Quarter Growth %)

 2023
 2022 2021 2020
IV Quarter December - - - 35.64 %
III Quarter September -22.35 % 26.1 % 2.32 % -
II Quarter June -9.84 % 110.38 % -27.92 % -
I Quarter March - - -40.77 % -
FY (Year on Year)   - -27.58 % - -


Current ZBH Income Statement >> Back to ZBH Growth rate Comparisons >>


Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #88
Overall #1272

Income from Cont. Operations Y/Y Growth Statistics
High Average Low
1595.87 % 132.49 % -62.97 %
(Dec 31 2017)   (Mar 31 2022)
Income from Cont. Operations third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #88
Overall #1272
Income from Cont. Operations Y/Y Growth Statistics
High Average Low
1595.87 % 132.49 % -62.97 %
(Dec 31 2017)   (Mar 31 2022)

Income from Cont. Operations by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Zimmer Biomet Holdings Inc 's Q/Q Income from Cont. Operations Growth


Income from Cont. Operations Q/Q Growth Statistics
High Average Low
1146.15 % 76.61 % -85.69 %
(Dec 31 2017)  


ZBH's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2023 Zimmer Biomet Holdings Inc reported fall in Income from Cont. Operations sequentially by -22.35% to $ 162.90 millions, from $ 209.80 millions achived in the previous quarter.

Those periodic influence were not able to recover the III. Quarter for the Zimmer Biomet Holdings Inc , Jessica T. Phillips, Healthcare sector contributor from Toronto said, she identified additional challenges onward for ZBH.

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 1357.


Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #91
Overall #1357
Income from Cont. Operations Q/Q Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry #34
Healthcare Sector #91
Overall #1357
Income from Cont. Operations Q/Q Growth Statistics
High Average Low
1146.15 % 76.61 % -85.69 %
(Dec 31 2017)  


ZBH's III. Quarter Q/Q Income from Cont. Operations Comment
In the III. Quarter 2023 Zimmer Biomet Holdings Inc disclosed fall in Income from Cont. Operations from the previous quarter by -22.35% to $ 162.90 millions, from $ 209.80 millions achived in the previous quarter.

Although seasonal factors which usually fuel III. Quarter 2023 results, it clearly could not be sufficient to recover Zimmer Biomet Holdings Inc 's III. Quarter outcome, Jessica T. Phillips, Healthcare sector contributor from Toronto said.

Within Medical Equipment & Supplies industry 33 other companies have achieved higher Income from Cont. Operations quarter on quarter growth. While Zimmer Biomet Holdings Inc 's Income from Cont. Operations growth quarter on quarter, overall rank is 1357.


Zimmer Biomet Holdings Inc 's 12 Months Income from Cont. Operations Growth Year on Year


Income from Cont. Operations TTM Growth

12 Months Ending
(Sep 30 2023)		 12 Months Ending
(Jun 30 2023)		 12 Months Ending
(Mar 31 2023)		 12 Months Ending
(Dec 31 2022)		 12 Months Ending
(Sep 30 2022)
Cumulative Income from Cont. Operations 12 Months Ending $ 475.20 $ 506.50 $ 450.70 $ 291.20 $ 337.50
Y / Y Income from Cont. Operations Growth (TTM) 40.8 % 75.2 % 62.36 % -27.58 % -58.83 %
Year on Year Income from Cont. Operations Growth Overall Ranking # 1827 # 695 # 535 # 1424 # 1241
Seqeuential Income from Cont. Operations Change (TTM) -6.18 % 12.38 % 54.77 % -13.72 % 16.74 %
Seq. Income from Cont. Operations Growth (TTM) Overall Ranking # 687 # 363 # 483 # 1417 # 295

New: More ZBH's historic Income from Cont. Operations Growth >>



Cumulative Income from Cont. Operations growth Comment
With the quarterly Income from Cont. Operations reported in the Sep 30 2023 period, Zimmer Biomet Holdings Inc 's cumulative twelve months Income from Cont. Operations were $ 475 millions, company would post below average annual Income from Cont. Operations growth of 16.74% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Zimmer Biomet Holdings Inc 's Income from Cont. Operations growth from the 209.8% growth in Jun 30 2023.

In the Healthcare sector 120 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 695 to 1827.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
2448.75 %
162.98 %
-121.42 %
 

Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 18
Healthcare Sector # 121
Overall # 1827

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
2448.75 %
162.98 %
-121.42 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 48
S&P 500 # 687
Cumulative Income from Cont. Operations growth Comment
With the quarterly Income from Cont. Operations reported in the Sep 30 2023 period, Zimmer Biomet Holdings Inc 's cumulative twelve months Income from Cont. Operations were $ 475 millions, company would post below average annual Income from Cont. Operations growth of -121.42% year on year, if the fiscal year would end at Sep 30 2023.
A slow-down in the Zimmer Biomet Holdings Inc 's Income from Cont. Operations growth from the 209.8% growth in Jun 30 2023.

In the Healthcare sector 120 other companies have achieved higher trailing twelve month Income from Cont. Operations growth. While Income from Cont. Operations growth total ranking has deteriorated compare to previous quarter from 695 to 1827.

Income from Cont. Operations TTM Q/Q Growth Statistics
High Average Low
2448.75 %
162.98 %
-121.42 %
 


Income from Cont. Operations TTM Y/Y Growth Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 18
Healthcare Sector # 121
Overall # 1827

Income from Cont. Operations TTM Y/Y Growth Statistics
High Average Low
2448.75 %
162.98 %
-121.42 %
 


Income from Cont. Operations TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 48
S&P 500 # 687




Other Income from Cont. Operations Growth
Medical Equipment & Supplies Industry Income from Cont. Operations Growth Trends and Statistics
Healthcare Sector Income from Cont. Operations Growth Statistics
Income from Cont. Operations Growth Trends for overall market
ZBH's Income from Cont. Operations Growth Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Income from Cont. Operations Growth
Lowest Ranking Income from Cont. Operations Growth
Income from Cont. Operations Growth for ZBH's Competitors
Income from Cont. Operations Growth for Zimmer Biomet Holdings Inc 's Suppliers
Income from Cont. Operations Growth for ZBH's Customers

You may also want to know
ZBH's Annual Growth Rates ZBH's Profitability Ratios ZBH's Asset Turnover Ratio ZBH's Dividend Growth
ZBH's Roe ZBH's Valuation Ratios ZBH's Financial Strength Ratios ZBH's Dividend Payout Ratio
ZBH's Roa ZBH's Inventory Turnover Ratio ZBH's Growth Rates ZBH's Dividend Comparisons



Companies with similar Income from Cont. Operations fall for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %Income from Cont. Operations for the quarter ending Sep 30 2023
Shockwave Medical Inc -0.05%$ -0.049 millions
Xeris Biopharma Holdings Inc -0.29%$ -0.295 millions
Tenet Healthcare Corp-0.75%$ -0.746 millions
U S Physical Therapy Inc-4.67%$ -4.672 millions
Universal Health Services Inc -4.98%$ -4.979 millions
National Research Corporation-5.09%$ -5.086 millions
Hca Healthcare Inc -5.13%$ -5.134 millions
Viatris Inc -6.41%$ -6.407 millions
-6.71%$ -6.710 millions
Mettler Toledo International Inc-8.60%$ -8.598 millions
Corcept Therapeutics Inc-9.78%$ -9.777 millions
Charles River Laboratories International inc -9.83%$ -9.826 millions
Third Harmonic Bio Inc -10.51%$ -10.506 millions
The Pennant Group Inc -10.65%$ -10.653 millions
Henry Schein Inc -11.73%$ -11.728 millions
Quest Diagnostics Inc-14.13%$ -14.130 millions
Carlisle Companies Incorporated-15.01%$ -15.008 millions
Stryker Corp-15.20%$ -15.196 millions
Zimmer Biomet Holdings Inc -16.12%$ -16.117 millions
Amgen Inc -19.27%$ -19.272 millions
Entera Bio Ltd -22.43%$ -22.432 millions
Regeneron Pharmaceuticals Inc -23.40%$ -23.402 millions
Pediatrix Medical Group Inc -25.75%$ -25.746 millions
Zynex inc -26.25%$ -26.247 millions
Evofem Biosciences Inc -26.26%$ -26.256 millions
Tenax Therapeutics Inc -32.39%$ -32.386 millions
Avantor Inc -35.09%$ -35.090 millions
Ufp Technologies Inc -40.15%$ -40.154 millions
Bio techne Corp-43.17%$ -43.173 millions
Royalty Pharma Plc-44.61%$ -44.615 millions


Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com